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Mutations in Multidomain Protein MEGF8
Identify a Carpenter Syndrome Subtype
Associated with Defective Lateralization
Stephen R.F. Twigg,1,11 Deborah Lloyd,1,11 Dagan Jenkins,2 Nursel E. Elc¸ioglu,3
Christopher D.O. Cooper,4 Nouriya Al-Sannaa,5 Ali Annagu¨r,6 Gabriele Gillessen-Kaesbach,7
Irina Hu¨ning,7 Samantha J.L. Knight,8 Judith A. Goodship,9 Bernard D. Keavney,9 Philip L. Beales,2
Opher Gileadi,4 Simon J. McGowan,10 and Andrew O.M. Wilkie1,*
Carpenter syndrome is an autosomal-recessive multiple-congenital-malformation disorder characterized by multisuture craniosynosto-
sis and polysyndactyly of the hands and feet; many other clinical features occur, and themost frequent include obesity, umbilical hernia,
cryptorchidism, and congenital heart disease. Mutations of RAB23, encoding a small GTPase that regulates vesicular transport, are
present in the majority of cases. Here, we describe a disorder caused by mutations in multiple epidermal-growth-factor-like-domains
8 (MEGF8), which exhibits substantial clinical overlap with Carpenter syndrome but is frequently associated with abnormal left-right
patterning. We describe five affected individuals with similar dysmorphic facies, and three of them had either complete situs inversus,
dextrocardia, or transposition of the great arteries; similar cardiac abnormalities were previously identified in a mouse mutant for the
orthologousMegf8. The mutant alleles comprise one nonsense, three missense, and two splice-site mutations; we demonstrate in zebra-
fish that, in contrast to the wild-type protein, the proteins containing all three missense alterations provide only weak rescue of an early
gastrulation phenotype induced by Megf8 knockdown. We conclude that mutations in MEGF8 cause a Carpenter syndrome subtype
frequently associated with defective left-right patterning, probably through perturbation of signaling by hedgehog and nodal family
members.We did not observe any subject with biallelic loss-of functionmutations, suggesting that some residualMEGF8 functionmight
be necessary for survival and might influence the phenotypes observed.The multiple-congenital-anomalies disorder Carpenter
syndrome (acrocephalopolysyndactyly type II [MIM
201000]) was first described by George Carpenter in 1901
in two siblings with craniosynostosis and polysyndac-
tyly;1 in 1909 he added a case report of a third affected
sibling in the family.2 Over 70 further cases have been
described in the clinical literature, and a large number of
additional phenotypic features have been noted and
include high birth weight and obesity in later life, congen-
ital heart disease, umbilical hernia, cryptorchidism in
males, and genu valgum.3–5 Although often arising sporad-
ically, consanguinity is frequent, and autosomal-recessive
mutations are presumed to underlie most cases.
In 2007 the majority of individuals with Carpenter
syndrome were shown by Jenkins et al. to have biallelic
mutations in RAB23 (MIM 606144), encoding a member
of the family of small guanosine triphosphatases (GTPases)
that regulate intracellular trafficking of membrane-
associated proteins.6 All together, Jenkins et al.6 and two
subsequent studies7,8 have reported RAB23 mutations in
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The Americanin 13 families have been homozygous for the identical
c.434T>A (p.Leu145*) mutation, indicating a major
founder effect in subjects of north European origin.
However, an additional ten distinct mutant alleles have
been described, consistent with complete loss of RAB23
function. The role of RAB23 as a negative regulator of
hedgehog (HH) signaling was originally defined by the
analysis of mutant phenotypes affecting the orthologous
murine Rab23 (open brain mutant);9 homozygous
mutants are more severely affected than humans in that
they die in mid gestation because of neural-tube
defects.9–11 Abrogation of RAB23 activity in human retinal
cells prevents formation of the primary cilium,12 suggest-
ing a likely mechanism linking to HH signaling,13 but
the biochemical details are poorly understood. One study
of canine cells proposed that Rab23 facilitates ciliary recy-
cling of Smoothened (Smo), a HH-signaling mediator,14
and genetic evidence in mice places the Rab23 mutation
downstream of Smo.15 Compatible with the latter obser-
vation, transcription of Gli1, a HH target, requires a phys-
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Figure 1. Clinical Features of Individuals with MEGF8 Mutations
(A–G) Subject 1 showing facial features at the age of 4.5 years (A), chest and side view at the age of 9 years (B), a chest radiograph at the
age of 9 years (C), clinical appearance of hands at the age of 4.5 years (D) and feet at the age of 9 years (E), and radiographs of hands and
feet at the age of 10 years (F and G). Note the tongue-like projections at the base of the proximal phalanges (F and G, arrowheads); these
are frequently noted in Carpenter syndrome.
(H and I) Facial features of subject 2 at the age of 6.4 years.Drosophila suppressor of fused (SUFU), another HH-sig-
naling component.16
Notwithstanding these gaps in knowledge, the origins of
the cardinal physical features of Carpenter syndrome are
better understood. In the limbs, reduced proteolytic pro-
cessing of the transcription factor GLI3 to its shorter re-
pressor form is the likely cause of polydactyly;15,17 in the
skull, a similar mechanism might operate because Gli3-
loss-of-function mouse mutants exhibit fusions of the
lambdoid and interfrontal sutures.18,19 The abnormalities
probably reflect disturbance of HH signaling, principally
mediated by sonic hedgehog (SHH) in the limbs17 and by
Indian hedgehog (IHH) in the cranial sutures.20,21 Also sup-
porting the close links with HH signaling, we found that
three subjects who had a clinical diagnosis of Carpenter
syndrome and inwhom RAB23mutationswere not present
instead harbored heterozygous deletions of GLI3 (MIM
165240).22 These individuals had several features (polysyn-
dactyly, congenital heart disease, and learning disability)
overlapping those of RAB23mutations, but craniosynosto-
siswas restricted to themidline sutures (metopicor sagittal),
and other somatic features (high birth weight, umbilical
hernia, and hypogenitalism in males) were absent.
Our starting point for this work was a simplex case (sub-
ject 1)—the offspring of first-cousin parents from Turkey—898 The American Journal of Human Genetics 91, 897–905, Novembwho was diagnosed with Carpenter syndrome. The study
was approved by Oxfordshire Research Ethics Committee
B (reference C02.143) and the Riverside Research Ethics
Committee (reference 09/H0706/20); written informed
consent for gathering samples for genetics research was ob-
tained from the parents. Although subject 1 exhibited the
cardinal features (including bicoronal craniosynostosis
with trigonocephaly and polysyndactyly) required for
diagnosing Carpenter syndrome, he also had dextrocardia,
which has not been described in association with RAB23
mutations (Figures 1A–1G and Table 1). DNA sequencing
of RAB23 was normal and showed that he was heterozy-
gous for a common intragenic SNP, rs1040461, excluding
an occult autozygous mutation. Analysis of GLI3 by DNA
sequencing and multiplex-ligation-dependent probe am-
plification analysis (MLPA) was also normal. These data
excluded known genetic causes of Carpenter syndrome.
On the basis of the consanguinity, we hypothesized that
this individual had a different, autosomal-recessive basis
for his condition.
We performed homozygosity mapping in the proband,
his unaffected sister, and both parents by using the Illu-
mina HumanCytoSNP-12 BeadArray (300K) and identified
nine >5 Mb regions, composing ~5% of the genome and
containing 1,030 genes, that were uniquely homozygouser 2, 2012
in the proband and that were thus likely to harbor a reces-
sive disease-causing mutation on the basis of the assump-
tion of autozygosity.23,24 We then performed exome
sequencing25 by using an Agilent SureSelect Human All
Exon Kit (v.1; 38 Mb) to capture exonic DNA from a library
prepared from 3 mg of the proband’s DNA. The enriched
DNA was sequenced on an Illumina GAIIx platform with
51 bp paired-end reads. We generated 4.1 Gb of sequence
that, after mapping with Bowtie software26 to the hg19
genome and removal of artifacts, resulted in an average
coverage of 433. Variants were called with the SAMtools
program.27 We identified 100,695 variants in the exome
sequence, which we prioritized by excluding (1) variants
present either in dbSNP131 or five other exomes from
subjects with unrelated clinical conditions, leaving 8,452;
(2) variants not mapping to regions previously shown to
be uniquely homozygous in subject 1, leaving 897; and
(3) variants located in introns (except splice sites) or
untranslated regions or that encoded synonymous substi-
tutions, leaving 166 variants for consideration. Manual
examination of this final list highlighted a homozygous
missense change (c.4496G>A [p.Arg1499His]) within
multiple epidermal-growth-factor-like-domains 8 (MEGF8
[MIM 604267]), which was confirmed by dideoxy sequenc-
ing (Figure S1, available online).We considered this variant
to be a strong candidate as the causative mutation because
an ethylnitrosourea (ENU)-induced homozygous missense
mutation (c.577T>C [p.Cys193Arg]) in the orthologous
mouse Megf8 was previously described in a mutant with
very similar phenotypic features, including abnormalities
of organ laterality in both the thoracic and abdominal
cavities and preaxial duplication of all four limbs, to those
of the proband.28,29
To gather further genetic evidence that MEGF8 muta-
tions could be causative of human phenotypes, we under-
took DNA sequencing of the coding region of MEGF8 in
additional unrelated subjects. MEGF8, located in chromo-
somal region 19q13.2, is transcribed into two major
splice forms, differing by the inclusion (Ensembl transcript
ENST00000251268.5) or exclusion of a single 201 nt exon
(12A, following exon 12) that does not alter the reading
frame. The reference cDNA (RefSeq accession number
NM_001410.2) constitutes the shorter splice form, which
comprises 41 exons and encodes a 2,778 amino acid
protein (Figures 2A and 2B). We selected two categories
of samples to study: (1) samples from individuals who
were referred because of a suspected diagnosis of Carpenter
syndrome but who had a normal RAB23 DNA sequence
(22 samples, including a recently published subject31
with Carpenter syndrome and complete situs inversus);
and (2) samples from individuals with complex forms
of congenital heart disease suggestive of heterotaxy but
without craniosynostosis or limb anomalies (15 samples;
see Table S1 for clinical details). Table S2 lists the primer
sequences and PCR conditions that we used to amplify
all 42 coding exons.We found nomutations in the isolated
heterotaxy group, indicating that MEGF8 mutations areThe Americannot a common cause of this phenotype. However, we did
identify plausible mutations in 3 of 22 samples (subjects
2, 3, and 4) in the Carpenter syndrome group, supporting
our hypothesis that the MEGF8 mutation was causative in
the original subject.
The DNA sequence changes found are illustrated in
Figure S1, and the mutations identified are summarized in
Table 2. In subject 2, we found compound heterozygosity
for a missense substitution (c.7099A>G [p.Ser2367Gly])
and a nonsense mutation (c.1342C>T [p.Arg448*]); in
subject 3 (offspring of first-cousin parents),31 there was
homozygosity for a missense substitution (c.595G>C
[p.Gly199Arg]); and in subject 4, there was heterozygosity
for two different splice-site mutations (c.3349þ3_3349þ
4dupAA and c.7069-2A>G). None of the mutations
identified are listed in either dbSNP135 or in the Exome
Variant Server; in addition, we excluded them from
ethnically matched normal control samples (192 samples
for c.7099A>G in northern European controls; 189
samples, kindly analyzed by E. Taskiran and N. Akarsu,
for c.1342C>T and c.595G>C in Turkish controls; and 41
samples for c.3349þ3_3349þ4dupAA and c.7069-2A>G
in Saudi Arabian and Jordanian controls). Analysis of
the splice-site mutations present in subject 4 with the
use of Splice Site Prediction by Neural Network showed
that the score for the c.7069-2A>G acceptor splice site of
exon 41 had changed from 0.71 to not recognized; this
change indicated that it would abolish splicing. For
c.3349þ3_3349þ4dupAA, the score for the splice donor
site of exon 19 was altered from 1.0 to 0.84, indicating
that the mutation would diminish the efficiency of
splicing but probably not abolish it. Unfortunately, we
were unable to demonstrate that the two mutations in
subject 4 were present on different alleles or that they
affected splicing because no sources of mRNA from the
proband, or DNA from other family members, were avail-
able for analysis. Although the evidence that MEGF8
mutations are causative in this family is insufficient for
constituting formal proof, we have included the clinical
details of the two affected cases because they resemble
subjects 1–3 in many aspects. The clinical features of
subject 2 are illustrated in Figure 1B, those of subject 3
were recently reported,31 and those of subjects 4 and 5
(an older sibling of subject 4, from whom no DNA was
available) are illustrated in Figure S2. Table 1 summarizes
the clinical features of all cases.
The positions of the mutations in the gene and encoded
protein are shown in Figure 2. The three missense substitu-
tions localize to three different conserved domains of
MEGF8: p.Arg1499His (in subject 1) is in a kelch domain,
p.Ser2367Gly (in subject 2) in an epidermal-growth-factor
(EGF)-like laminin domain, and p.Gly199Arg (in subject 3)
in an EGF domain. MEGF8 is highly conserved in meta-
zoans; for example, linear homology between the human
and Drosophila orthologs can be traced over >2,400 amino
acids, including 33% identities. With the use of SMART
profiling,30 homologs including each of the domains inJournal of Human Genetics 91, 897–905, November 2, 2012 899
Table 1. Clinical Features of Subjects with Mutations in MEGF8
Subject Gender
Birth
Weight
Cranio-
synostosis
Craniofacial
Features
Digit Length
and Position
Cutaneous
Syndactyly Polydactyly
Cardiac
Features Genitalia Other Height Weight
Developmental
Attainment
1 M 4,500 g
(þ1.9 SDs)
RC and LC
trigono-
cephaly
hypertelorism,
epicanthus,
upslanted
palpebral
fissures, blue
sclerae, sparse
eyebrows, low-
set ears with
increased
posterior
angulation,
narrow nares,
long philtrum,
retrognathia,
malocclusion,
high narrow
palate, and
multiple dental
caries
camptodactyly
(H), broad
radially
deviated
thumbs, short
digits (F)
1–5 (F) bilateral
postaxial
polydactyly
type B (H),
preaxial
polydac-
tyly (F)
dextrocardia small penis,
shawl
scrotum,
bilateral
cryptor-
chidism
short webbed
neck, umblical
hernia, pectus
carinatum on
left, wide-
spaced
hypoplastic
nipples,
accessory
nipples, flexion
contracture
at knees
102 cm at
4.5 years
of age
(1.0 SD)
18.2 kg at
4.5 years
of age
(þ0.3 SD)
DQ 78 at
4.5 years
of age
2 F 3,620 g
at 38 weeks
of age
(þ1.5 SDs)
Me hypertelorism,
epicanthus,
upslanted
palpebral
fissures, depressed
and wide nasal
bridge, high
palate
broad radially
deviated
thumbs,
short digits
(H and F),
equinovarus
right foot
2/3 (H); 1/2,
4/5 (F)
none transposition
of great arteries,
atrial septal
defect, patent
ductus arteriosus,
tricuspid
insufficiency
normal coxa vara, mild
sensorineural
hearing loss,
hypoplastic
wide-spaced
nipples
132 cm at
6.5 years
of age
(þ2.1 SDs)
47 kg at
6.5 years
of age
(þ3.5 SDs)
IQ 109 at
5.8 years
of age
(verbal 124,
nonverbal 88)
3 M 4,000 g
(þ1.3 SDs)
Me and S prominent
forehead
fifth-finger
clinodactyly
3/4 (H),
1/2 (F)
preaxial
polydac-
tyly (F)
dextrocardia
associated with
situs inversus
totalis
bilateral
cryptor-
chidism
wide-spaced
nipples
4 M 4,739 g
(þ2.3 SDs)
Me highly arched
eyebrows,
hypertelorism,
epicanthus,
ectropion
of lower eyelids
with bilateral
nasolacrimal
duct obstruction,
depressed nasal
bridge, enlarged
anteverted nares,
midface retrusion,
narrow palate,
low-set ears with
increased posterior
angulation
camptodactyly
(H), short
digits (H),
absent middle
phalanges
(H and F), single
transverse
palmar creases
(H), talipes
equinovarus (F)
partial
1–5 (H),
complete
1–5 (F)
none patent ductus
arteriosus
bilateral
undescended
testes
generally loose
skin with
excessive folds,
broad short
neck, wide-
spaced nipples,
pectus excavatum,
bilateral
eventration of
diaphragm with
central position of
liver, no structural
brain anomalies,
normal karyotype
77 cm at
10 months
of age
(þ1.4 SDs)
11.8 kg at
10 months
of age
(þ2.0 SDs)
hypotonia
and delayed
milestones;
sat with
support at
10 months
of age
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s.The Americanwhich mutations were found can be identified in many
diverged animal species, including sea squirts (Ciona),
lancelets (Branchiostoma), sea urchins (Strongylocentrotus),
insects (Drosophila), and sea anemones (Nematostella).
Homologies can also be detected for ATTRACTIN, a protein
that modulates hair pigmentation (mahogany mutation)
in mice.32
To assess the pathogenic significance of the missense
substitutions, we examined their deep evolutionary
sequence conservation and mapped the mutations onto
crystallographic structures of related family members
(Figure S3). Gly199 (in subject 3) locates to a highly
conserved position within an EGF domain and is between
two cross-linked cysteine residues; only glycine at this
position can permit the required bending in the main
chain (Figure S3A).33 Also of note is that the mouse
Megf8 ENU mutation locates just six amino acids away at
one of these cysteine residues (Cys193).29 Arg1499 (in
subject 1) locates at a highly conserved position of a kelch
domain within the second blade of a predicted six-bladed
propeller; arginine at this position is highly conserved,
and in the related human kelch-like ECH-associated pro-
tein 1 (KEAP1), it forms hydrogen bonds both with the
carbonyl group of a highly conserved glycine residue and
with glutamate or aspartate residues and thus stabilizes
the intrablade structure (Figure S3B).34,35 Mutations at
one (Arg413) of these residues in KEAP1 have been re-
ported in lung cancer.36 Ser2367 (in subject 2) in an EGF
laminin domain is less highly conserved—threonine and
asparagine (but never glycine) are observed in homologous
proteins. The structure of the related laminin-g1 chain37
shows that this residue is surface exposed, making it diffi-
cult to predict the consequence of substitution at this
position. From this analysis, we considered the evidence
for pathogenicity to be strong for the p.Gly199Arg and
p.Arg1499His substitutions (in subjects 3 and 1, respec-
tively), both of which were present in a homozygous
state, but weaker for the p.Ser2367Gly substitution (in
subject 2), present in trans with a predicted null allele. To
further explore the significance of the p.Ser2367Gly sub-
stitution, we heterologously expressed and purified the
corresponding EGF laminin domain (residues Asp2326 to
Lys2399) in E.coli38 and analyzed the domain structure
by using far-UV circular-dichroism spectroscopy. However,
we found that the normal protein exhibits a low degree
of secondary structure, as seen for other EGF (-like)
domains,39 limiting the ability to detect potential pertur-
bations induced by the mutation (Figure S4).
As an alternative, biological test of pathogenicity, we
explored the consequence of knocking down expression
of the unique zebrafish megf8 ortholog by using two
validated morpholinos.29 Experimental procedures were
performed inaccordancewithUKAnimals (Scientific Proce-
dures) Act, 1986. In addition to reproducing the previously
described heart-looping defects, we observed at 10 hr post-
fertilization (hpf) abnormal gastrulation cell movements,
characterized by a short and wide notochord withJournal of Human Genetics 91, 897–905, November 2, 2012 901
Figure 2. Structure of MEGF8, Domain Organization of the Encoded Protein, and Position of Mutations Identified in Carpenter
Syndrome
(A) Cartoon shows organization of the 41 exon MEGF8. The reference sequence omits the alternatively spliced exon 12A (red box).
(B) Domain organization of encoded protein shows motifs identified by SMART analysis.30discontinuous expressionofno tail (ntl) anddelayedclosure
of the blastopore (epiboly defects; Figure 3A). We observed
similar defects after knockdownof rab23 (D.J., unpublished
data). To investigate the consequences of the identified
MEGF8 missense substitutions on protein function, we
tested for genetic rescue of these defects after coinjection
ofMEGF8 RNA, which shares no significant sequence simi-
larity with the morpholino. Whereas 83% of embryos in-
jected with 6 ng of megf8 morpholino exhibited epiboly
defects, only 12% of embryos coinjected with wild-type
MEGF8 RNA were affected, indicating a significant rescue
(p < 0.0001) and that the human gene can functionally
compensate for the zebrafish ortholog (Figure 3B). We
then introduced each of the nucleotide changes causing
missense substitutions into thehumancDNAbyPCR-medi-
ated mutagenesis and confirmed the sequence integrity of
each construct. Coinjection of any of the three missense
mutant versions of MEGF8 did not result in an effective
rescue (Figure 3B); however, the reduced proportion of
epiboly defects (60%–73%) compared to that caused by
morpholino knockdown alone raises the possibility that
the mutant proteins might harbor some residual function.
Putting the genetic, structural, and functional evidence
together, we conclude that biallelic mutations of MEGF8
result in a phenotype closely resembling classical Car-
penter syndrome caused by RAB23 mutation. Detailed ex-
amination of the clinical features (Figure 1 and Table 1)
suggests that the spectrum of limb anomalies associated
with mutations in the two genes is very similar andTable 2. MEGF8 Mutations Identified in Individuals Presenting with C
Subject Subject ID Consanguineous Parents Country of O
1 OX4128 first cousins Turkey
2 OX4170 no Germany
3 OX5151 first cousins Turkey
4 OX4865 first cousins Saudi Arabia
aSample not available from the mother, but MLPA analysis in subject 3 showed t
bSamples from subject 5 (sibling) and the parents were not available, so parental or
tions was not formally established.
902 The American Journal of Human Genetics 91, 897–905, Novembincludes brachydactyly, syndactyly, and preaxial polydac-
tyly; radiographic examination of the limbs of subject 1
showed unusual epiphyseal spurs (Figures 1F and 1G)
reminiscent of those described in classical Carpenter
syndrome.3,4,6 Subjects withMEGF8mutations show addi-
tional features resembling the RAB23 mutant phenotype,
and these include a tendency toward high birth weight
and childhood obesity and the occurrence of cryptorchi-
dism or undescended testes in males. However, there are
subtle differences in many other clinical features. Cranio-
synostosis tends to be less severe in the case of MEGF8
mutations and usually involves only the metopic suture.
This is frequently accompanied by paradoxical hyper-
telorism, associated with a distinctive dysmorphic facies
comprising a broad depressed nasal bridge, epicanthus, up-
slanted palpebral fissures, highly arched eyebrows, and
low-set, posteriorly angulated ears (Figure 1 and Figure S2).
Defects of lateralization were present in at least three
subjects and ranged from transposition of the great arteries
(in subject 2) to dextrocardia (in subject 1) to complete
situs inversus (in subject 3). Subjects 4 and 5 were both
diagnosed with diaphragmatic eventration and a central
position of the liver, although the clinical information
was incomplete. The range of cardiac defects closely
mirrors those associated with the previously described
mouse mutation28,29 but is rare with RAB23 mutations,
although two cases of polysplenia (another manifestation
of defective lateralization) have been recorded.7,8 How-
ever, we excluded the possibility that MEGF8 mutationsarpenter Syndrome
rigin Allele 1 (Paternal) Allele 2 (Maternal)
c.4496G>A (p.Arg1499His) c.4496G>A (p.Arg1499His)
c.1342C>T (p.Arg448*) c.7099A>G (p.Ser2367Gly)
c.595G>C (p.Gly199Arg) c.595G>C (p.Gly199Arga)
c.3349þ3_3349þ4dupAAb c.7069-2A>Gb
hat the mutation was present in two copies.
igins shown here are arbitrary, and compound heterozygosity of the two muta-
er 2, 2012
Figure 3. Functional Analysis of MEGF8
Missense Substitutions in Zebrafish
Embryos
(A) In situ hybridization of ntl at 10 hpf for
labeling the notochord and blastoderm
margin, shown in dorsal view. Embryos in-
jected with 6 ng ofmegf8moE229 exhibited
severe epiboly defects (right), characterized
by the shortening and widening of the
notochord, discontinuous staining (indi-
catedby the arrow), andanopenblastopore
(asterisk). Embryos injected with control
morpholino (MO) are shown on the left.
(B) Quantification of epiboly defects and
genetic rescue. Shown are the propor-
tions of embryos injected with the indi-
cated dose of megf8 morpholino and
different versions of MEGF8 RNA (wild-
type [WT] or missense mutant forms
[c.595G>C (p.Gly199Arg), c.4496G>A
(p.Arg1499His), or c.7099A>G
(p.Ser2367Gly)]) either in combination or
alone. p values correspond to statistical
differences compared to uninjected em-
bryos according to a Fisher’s exact test
(two-tailed). megf8 MOs and standard
control MOs were purchased from Gene
Tools. A full-length (41 exon) MEGF8
cDNA clone was obtained from Origene,
and mutant versions encoding each mis-
sense mutation were generated with the QuikChange Site-Directed Mutagenesis Kit (Stratagene) (see Table S2 for oligonucleotides).
All clones were sequence verified and subcloned into pcDNA3-DEST53 with Gateway cloning (Invitrogen). Capped RNAwas synthesized
with the mMESSAGE mMACHINE kit (Ambion). Wild-type zebrafish (Danio rerio) embryos were raised at 28.5C, and microinjections
(~1 nl) were performed at the 1-cell stage. In situ hybridization was performed with RNA probes labeled with digoxigenin (Roche)
and detected with BCIP/NBT (5-bromo-4-chloro-3-indolyl phosphate/nitro blue tetrazolium) (Sigma).commonly cause cardiac malformations related to
disturbed laterality in the absence of additional syndromic
features (Table S1). Wide-spaced, hypoplastic, and/or
supernumerary nipples and thoracic skeletal abnormalities
also seem more characteristic of MEGF8 mutations;
conversely, umbilical hernia and genu valgum, two prom-
inent features of the RAB23-mutant phenotype, appear less
characteristic of MEGF8 mutation.
Despite these differences, the many overlapping features
of the mutant phenotype suggest that RAB23 and MEGF8
might be closely related in their developmental role
and cellular actions. An apparent paradox raised by this
conclusion is that although MEGF8 (2,778 amino acids)
represents a far larger target for mutation than does
RAB23 (237 amino acids), mutations in RAB23 seem to
outnumber those in MEGF8 by ~8:1. One explanation
might be the lack of a major founder effect for MEGF8
mutations given that no mutant allele was identified inde-
pendently more than once (Table 2). Another possibility
is that the Carpenter syndrome phenotype associated
with MEGF8 mutations arises only in a narrow window
of residual protein activity (hypomorphic mutation); no
affected individual had two alleles predicting complete
loss of function, compatible with the notion that homozy-
gosity for the null state might be lethal (as occurs in other
recessive disorders).40 Variation in the amount of residual
activity might cause clinical variability (for example, in
the degree of intellectual disability, which did not showThe Americana consistent pattern) between individuals with different
combinations of mutations.
Given the deep evolutionary origins of MEGF8, which
was first identified in 1998 in a screen for proteins contain-
ing EGF motifs,41 surprisingly little is currently known
about its functions. The presence of multiple domains
with recognized protein-binding potential and a predicted
transmembrane domain near the C terminus (Figure 2B)
might suggest actions in cell-surface recognition. How-
ever, previous analyses using an antibody directed to an
N-terminal epitope did not observe cell-surface expression
and instead described intracellular localization, both cyto-
plasmic and nuclear.29 In zebrafish, the megf8 ortholog
was found to be ubiquitously expressed, and morpholino
knockdown disturbed left-right patterning—75% of em-
bryos were observed to have discordant situs.29 Although
mouse embryos homozygous for the p.Cys193Arg sub-
stitution showed asymmetric expression of Nodal at the
node (indicating that the earliest stages of symmetry
breaking were intact), the fact that the normally asym-
metric expression of Nodal in the lateral plate mesoderm
was lost indicates a defect in transduction of the asym-
metric signal from the node by an unknown mecha-
nism.29 A clue to how Megf8 might be working bio-
chemically is provided by recent studies on mouse Atrn
(attractin), which appears to be the closest relative of
Megf8 and shares several similar domains (Figure S3). At-
tractin was shown to affect the fate of membrane-boundJournal of Human Genetics 91, 897–905, November 2, 2012 903
receptor molecules by determining their trafficking to
either the lysosome or to the cell surface;32 an analogous
function for MEGF8 in intracellular trafficking could
account for both the presence of the predicted transmem-
brane domain and the phenotypic similarity in the conse-
quences of MEGF8 and RAB23 mutations.Supplemental Data
Supplemental Data include four figures and two tables and can be
found with this article online at http://www.cell.com/AJHG.Acknowledgments
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